- Schultz C, Scott C, Sherman W, Donahue B, Fields J, Murray K, Fisher B, Abrams R, and Meis-Kindblom, J: Pre-irradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary central nervous system lymphomas: Initial Report of Radiation Therapy Oncology Group (RTOG) protocol 88-06. J Clin Oncol, 14:556-564, 1996.
- Auchter RM, Lamond JP, Alexander E, Buatti JM, Chappell RJ, Friedman W, Kinsella TJ, Levin AB, Noyes WR, Schultz C, Loeffler JS, and Mehta MP: A multi-institutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. Int J Rad Oncol Biol Phys, 35:27-35, 1996. (Awarded the ASTRO Resident Essay Award, 1995.)
- Hung RT, Jindal JR, Clowry LJ, Schultz C, Freije, JE: Giant cell carcinoma of the parotid gland. Otolaryngology Head Neck Surg, 114:657-660, 1996.
- Freije JE, Beatty TW, Campbell BH, Woodson BT, Schultz CJ, and Toohill RJ: Carcinoma of the larynx in patients with gastroesophageal reflux. American Journal of Otolaryngology, 17:386-390, 1996.
- Campbell BH, Mark DH, Soneson E, Freije JE and Schultz CJ: The Role of Dental Prosthesis in Alveolar Ridge Squamous Carcinomas. Archives of Otolaryngology, 123(10) 112-115, 1997.
- Boyd TS, Harari PM, Voytovich MC, Hartig GK, Ford CN, Campbell BH, Foote RL, and Schultz CJ: Planned Post-radiotherapy Neck Dissection in Patients with Advanced Head and Neck Cancer: Head and Neck 20:132-137, 1998.
- Adamson A., Rand S., Prost R., Kim T., Schultz C., Haughton V. The Effect of Single Voxel Proton MRS on the Management of Patients with Focal Lesions of the Brain. Radiology, 209(1): 73-78, 1998.
- Prados M., Scott C., Sandler H., Buckner J., Phillips T., Schultz C., Urtasun R., Davis R., Gutin P., Cascino T., Greenberg H., and Curran W. A Phase III Randomized Study of Radiotherapy with or without BudR plus Procarbazine, CCNU and Vincristine (PCV) for the Treatment of Anaplastic Astrocytoma: A Preliminary Report of RTOG 94-04. Int J Rad Onc Bio Phys 45(5):1109-1115, 1999.
- Corn B, Dolinskas C, Scott C, Donahue B, Schultz C, Nelson D, Fisher B. Strong Correlation Between Imaging Response and Survival Among Patients with Primary Central Nervous System Lymphoma. Int J Rad Onc Biol Phys 47(2):299-303, 2000.
- Spencer S, Harris J, Wheeler R, Machtay M, Schultz C, Sparros W, Rothman M, and Meredith R. RTOG 96-10 Phase I study of reirradiation (RRT) with concurrent Hydroxyurea (HU) and 5-Fluorouracil (FU) in patients (PTS) with squamous cell cancer of the head and neck (SCH&N) Int J Rad Onc Biol Phys 51(5):1299-1304, 2001.
- DeAngelis LM, Seifenheld WS, Schold SC, Fisher B, and Schultz CJ: Combination chemotherapy and radiotherapy for newly diagnosed patients with primary central nervous system lymphoma: RTOG 93-10. Journal Clinical Oncology 20:24, pp4643-4648, 2002.
- Mehta MP, Shapiro W, Glantz MJ, Patchell RA, Weitzner MA, Meyers CA, Schultz CJ, et al: Lead-in phase to randomized trial of Motexafin Gadolinium and whole brain radiation for patients with brain metastasis: Centralized assessment of MRI, neurocognitive, and neurologic endpoints. Jour Clin Oncol, 20:16, 3445-3453, 2002.
- Jursinic P, Prost R, and Schultz C: A new magnetic resonance head coil and head immobilization device for gamma knife radiosurgery: An analysis of geometric distortion and signal/noise characteristics. J Neurosurg (Suppl 5) 97:563-568, 2002.
- Ambinder RF, Lee S, Curran WJ, Sparano JA, Krigel RL, McArthur J, Schultz CJ, et al. Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary CNS Lymphoma. Cancer Therapy, Vol 1, 215-221,2003.
- Chang C, Kampalath B, Schultz C et al: Expression pf p53 and c-Myc correlates with survival in primary CNS diffuse large B-cell lymphoma in immunocompetent individuals. Arch Pathol Lab Med, Vol 127, 208-212, 2003.
- Mehta MP, Rodrigus P, Terhaard CHJ, Rao A, Suh J, Roa W, Souhami L, Bezjak A, Leibenhaut M, Komaki R, Schultz C, et al: Survival and neurological outcomes in a randomized trial of motexafin gadolinium and whole brain radiation therapy in brain metastases. Journal of Clinical Oncology, 21:13, 2529-2536, 2003.
- Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, Ensley JF, Chao, C, Schultz C, et al. Postoperative concurrent chemotherapy and radiation therapy in high-risk squamous cell carcinoma of the head and neck region: The RTOG 9501/intergroup phase III trial. (Accepted New Eng Jour of Med 12/03)
- Souhami L, Scott C, Brachman D, Podgorsak E, Werner-Wasik M, Lustig R, Schultz C et al. Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: Report of RTOG 93-05 protocol. (Submitted to to Int J Rad Onc Biol Phys 12/03)
- Fisher BJ, Sieferheld W, Schultz C, et al: Secondary analysis of RTOG 93-10; An intergroup phase II combined modality treatment of primary central nervous lymphoma (Submitted to Int J Rad Onc Biol & Phys 11/03)
- Spencer SA, Harris J, Wheeler, RH, Machtay M, Schultz CJ et al. Late Effects of RTOG 96-10. Re-irradiation and Chemotherapy in Patients with Squamous Cell Carcinma of the Head and Neck. (Submitted to Int J Rad Onc Biol & Phys 1/04)
- Zhu XR, Schultz CJ, Gillin MT. Treatment Planning Quality and Delivery Effeciency for sMLC Delivered IMRT Treatment of Oropharyngeal Cancer: A Comparative Planning Study Evaluated by RTOG H-0022 Dosimetric Criteria. (Submitted to Int J Rad Onc Biol Phys 1/04)
- Prados M, Seiferheld W, Sandler H, Buckner, JC, Phillips T, Schultz C et al: 42. RTOG 94-04: A phase III randomized study of radiotherapy plus Procarbazine, CCNU, and Vincristine (PCV) with or without BudR for the treatment of anaplastic astrocytoma. Int J Rad Onc Bio Phys 58 (4):1147-1152, 2004.
- Schultz C, Mueller W, Zellmer D, Derus S: Semi-continuous Low-Dose Rate Teletherapy for the Treatment of Recurrent Glial Brain Tumors: The Preliminary Report of a Phase I Study. (Submitted to to Int J Rad Onc Biol Phys 5/04)
- Schultz C, Whittaker M: Correlation of Incidence and Significance of EBV Infection in Primary CNS Lymphoma Patients Treated on RTOG Protocol #83-15 and #88-06. September 2002 (Submitted to Int J Rad Onc Biol Phys 5/04)
- Schultz C, Scott C, DeAngelis L, Nelson D, Nelson J, Schoid Jr C, and Curran Jr W. Radiation Therapy (RT) Alone vs Pre-RT Chemotherapy (CTX) for the Treatment of Primary CNS Lymphoma (PCNSL): Age Matched Survival Analysis of RTOG 83-15 and RTOG 88-06. (Submitted to J. Clinical Oncology 6/04)
-
Jursinic P, Rickert K, Gennarelli T, Schultz C. Effect of Image Uncertainty on the Dosimetry of Trigeminal Neuralgia Irradiation: Int J Rad Onco Biol Phys 62:5,1559-1567, 2005.
-
Robins HI, Won M, Seiferheld W, Schultz C, et al: A phase II trial of conventional radiation therapy plus high dose tamoxifen for the treatment of supratentorial glioblastoma multiforme: RTOG protocol BR-0021. Neuro-Oncology 8(1):47-52 Jan 2006.
-
Cardinale R, Won M, Choucari A, Gillin M, Chakravarti A, Schultz C, et al: A Phase II Trial of Accelerated Radiotherapy Using Weekly Stereotactic Conformal Boost for Supratentorial Glioblastoma Multiforme RTOG 0023. Int J Rad Onc Biol Phys 65:5 1422-1428, 2006.
-
Gabayan A, Green S, Sanan A, Jenrette J, Schultz C, Papagikos M, Tatter S, Patel A, P Amin P, Tonnesen G, Lustig L, Bastin B, Watson G, Burri S, Stea B. GliaSite® brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional study: Neurosurgery 58:4, 701-709, 2006.
-
Qi XS, Schultz CJ, Li ZA: An estimation of radiobiologic parameters from cinical outcomes for radiation treatment planning of brain tumor. Int J Rad Onc Bio Phy 64:5, 1570-1580, 2006.
-
Wang D, Schultz C, Jursinic P, et al: Initial experience of FED/PET/CT guided IMRT of head and neck carcinoma, Int J Rad Onc Biol & Phys 65:1, 143-151, 2006.
-
Colman H, Berkey B, Maor M, Groves, M, Schultz C, et al: Phase II RTOG Trial of Conventional Radiation Therapy Followed by Treatment with Recombinant Interferon-B for Supratentorial Glioblastoma: Results of RTOG 9710. Int J Rad Onc Biol & Phs 66:3, 818-824, 2006.